LYEL (LYELL IMMUNOPHARMA INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold LYEL (LYELL IMMUNOPHARMA INC) with a combined value of $17.65M across 573,508 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $10.49M (0.00% of their portfolio). Point72 Asset Management, L.P. opened a new position in the most recent quarter. 1 fund increased its holdings. 2 funds reduced their position.
Total Institutional Value
$17.65M
Total Shares Held
573,508
Institutional Holders
4
Recent Activity
Point72 Asset Management, L.P.New Position
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $10.49M | 0.00% | -4.4% |
| 2 | BlackRock, Inc. | $5.60M | 0.00% | +2.8% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $1.22M | 0.00% | -38.3% |
| 4 | Point72 Asset Management, L.P. | $353.35K | 0.00% | New |